Back
Theravance Biopharma 10K Form
Sell
42
TBPH
Theravance Biopharma
Last Price:
9.46
Seasonality Move:
-13.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TBPH News And Ratings
See the #1 stock for the next 7 days that we like better than TBPH
TBPH Financial Statistics
Sales & Book Value
Annual Sales: | $57.42M |
---|---|
Cash Flow: | $-1.53M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.43 |
Price / Book: | 2.14 |
Profitability
EPS (TTM): | -0.97000 |
---|---|
Net Income (TTM): | $-55.19M |
Gross Margin: | $71.86M |
Return on Equity: | -17.79% |
Return on Assets: | -11.56% |
Theravance Biopharma Earnings Forecast
Key Theravance Biopharma Financial Ratios
- The Gross Profit Margin over the past 9 years for TBPH is 100.00%.
- The Selling, General & Administrative Expenses for TBPH have been equal to 122.69% of Gross Profit Margin.
- The Research & Development expenses have been 70.74% of Revenue.
- The Interest Expense is -4.26% of Operating Income.
- The Net Earning history of TBPH is -96.11% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 5 years.
Theravance Biopharma Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | TBPH |
CUSIP: | G8807B |
Website: | theravance.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.39 |
Quick Ratio: | 4.84 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 27.42 |
TBPH Technical Analysis vs Fundamental Analysis
Sell
42
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy or a Sell?
-
Theravance Biopharma stock is rated a Sell
The current Theravance Biopharma [TBPH] share price is $9.46. The Score for TBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.